RME Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Resmed Inc

Watchlist Manager

Watchlist

Price: 199.25 EUR -2.85%

Market Cap: €29.3B

R	Resmed Inc F:RME	US
L	Longino & Cardenal SpA MIL:LON	IT
	Grown Rogue International Inc OTC:GRUSF	US
C	Canadian Pacific Kansas City Ltd F:X88	CA
A	Arcosa Inc SWB:EOB	US
L	Lockheed Martin Corp DUS:LOM	US
D	DSV A/S XMUN:DS81	DK
	Regions Financial Corp NYSE:RF	US
P	Perdoceo Education Corp XMUN:CE1	US
	Emyria Ltd ASX:EMD	AU
	KMD Brands Ltd ASX:KMD	NZ
E	Everpure Inc SWB:6PU	US
C	Cognex Corp F:CGZ	US
	Alstom SA F:AOMU	FR

Profitability Summary

Resmed Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

55% > 61%

Exceptional Operating Margin

34%

Strong 3Y Average Operating Margin

32%

Operating Margin is Increasing

27% > 34%

Healthy Net Margin

27%

Sustainable 3Y Average Net Margin

25%

Net Margin is Increasing

21% > 27%

Exceptional Free Cash Flow Margin

29%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

18% > 29%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

20%

ROIC is Increasing

17% > 22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.